Cite
Adams O, Janser FA, Dislich B, et al. Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas. PLoS One. 2019;14(10):e0224832doi: 10.1371/journal.pone.0224832.
Adams, O., Janser, F. A., Dislich, B., Berezowska, S., Humbert, M., Seiler, C. A., Kröll, D., Slotta-Huspenina, J., Feith, M., Ott, K., Tschan, M. P., & Langer, R. (2019). Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas. PloS one, 14(10), e0224832. https://doi.org/10.1371/journal.pone.0224832
Adams, Olivia, et al. "Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas." PloS one vol. 14,10 (2019): e0224832. doi: https://doi.org/10.1371/journal.pone.0224832
Adams O, Janser FA, Dislich B, Berezowska S, Humbert M, Seiler CA, Kröll D, Slotta-Huspenina J, Feith M, Ott K, Tschan MP, Langer R. Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas. PLoS One. 2019 Oct 30;14(10):e0224832. doi: 10.1371/journal.pone.0224832. eCollection 2019. PMID: 31665193; PMCID: PMC6821054.
Copy
Download .nbib